White Guide and Orange Guide Formatting Project - Pfizer

Orange Guide - Chapter 10: Starters
more information on the distribution of starters in these government institutions, see the White Guide
and Orange Guide Chapters on Federal Employee Interactions and Lobbying.
Sales Colleagues must learn the sample policies of any institution that they call on and follow those
rules, unless they conflict with Pfizer policy or the PDMA. If there are any questions about whether
a customer’s sample policies are consistent with Pfizer policies on starter distribution, Sales
Colleagues should contact Starter Operations or a Regional Attorney before leaving starters with
that customer.
Starters May Not Be Distributed for Research, Charitable Activities or To Defray Patients’
Pharmacy Expenses
Starters may not be used for clinical trials or other research activities; nor may they be provided to non-
profit organizations for missions or other charitable activities or to HCPs for distribution to patients as a
means of mitigating their medication costs. A request for medication or other clinical supplies to
support legitimate scientific investigations must be referred to the relevant Medical team for
consideration as an Investigator-Initiated Research (IIR) grant. (For more information on scientific
research, see the White Guide and Orange Guide Chapters on Clinical Research and Investigator-
Initiated Research.) HCPs seeking to assist their patients in mitigating their medication costs can be
referred to Pfizer Helpful Answers. (For more information, see the Patient Assistance Program
Chapter.)
Requests for medication from charities or from healthcare providers for charitable missions should be
directed to the Pfizer Corporate Responsibility department.
Managing Starters
As required by law and Pfizer policy, Sales Colleagues must adhere to strict requirements regarding
documentation of their receipt and delivery of starters and management of their starter inventory.
Starter Storage Requirements
Starters must be stored securely and under temperature-controlled conditions in accordance with the
product’s labeling to maintain their integrity, stability and efficacy. They are to be stored away from
188
Rev. 09/12
Page 12 of 17